Evidence map›Paper›PMID 32516203›Full record

ArticleThe American journal of gastroenterology2020

Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.

Douglas C Wolf, Christine H Wolf, David T Rubin

Open access · greenAbstract readCase Reports
In one paragraph

Article in The American journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
    Pooled it
  2. Article
  3. Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?International journal of molecular sciences · 2024
    Review
  4. Review
  5. Metal-based complexes against SARS-CoV-2.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Douglas C WolfCenter for Crohn's and Colitis, Atlanta Gastroenterology Associates, Atlanta, Georgia, USA.
Christine H WolfCenter for Crohn's and Colitis, Atlanta Gastroenterology Associates, Atlanta, Georgia, USA.
David T RubinUniversity of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Atlanta Gastroenterology Associates · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aged, 80 and overAnemiaAntidiarrhealsBetacoronavirusBismuthBlood SedimentationCoronavirus InfectionsCoughCOVID-19C-Reactive ProteinCrohn DiseaseDiarrheaHumansLymphopeniaMaleOrganometallic CompoundsAntidiarrhealsBismuthbismuth subsalicylateC-Reactive ProteinOrganometallic CompoundsSalicylates

Identifiers

PMID32516203
PMCPMC7302082
OpenAlexW3033531806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.